Protara Therapeutics, Inc. (TARA)
2.63
-0.14
(-5.05%)
USD |
NASDAQ |
Oct 13, 16:00
2.67
+0.04
(+1.52%)
After-Hours: 20:00
Protara Therapeutics Total Return Level : 2.77 for Oct. 12, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 12, 2026 | 2.77 |
| October 09, 2026 | 2.755 |
| October 08, 2026 | 2.65 |
| October 07, 2026 | 2.59 |
| October 06, 2026 | 2.555 |
| October 05, 2026 | 2.63 |
| October 02, 2026 | 2.70 |
| October 01, 2026 | 2.76 |
| September 30, 2026 | 3.05 |
| September 29, 2026 | 3.21 |
| September 28, 2026 | 3.25 |
| September 25, 2026 | 3.28 |
| September 24, 2026 | 3.35 |
| September 23, 2026 | 3.54 |
| September 22, 2026 | 3.68 |
| September 21, 2026 | 3.51 |
| September 18, 2026 | 3.55 |
| September 17, 2026 | 3.70 |
| September 16, 2026 | 3.62 |
| September 15, 2026 | 3.75 |
| September 14, 2026 | 3.91 |
| September 11, 2026 | 3.82 |
| September 10, 2026 | 3.79 |
| September 09, 2026 | 3.83 |
| September 08, 2026 | 3.89 |
| Date | Value |
|---|---|
| September 04, 2026 | 3.94 |
| September 03, 2026 | 3.97 |
| September 02, 2026 | 3.94 |
| September 01, 2026 | 3.90 |
| August 31, 2026 | 3.86 |
| August 28, 2026 | 3.82 |
| August 27, 2026 | 3.99 |
| August 26, 2026 | 3.91 |
| August 25, 2026 | 3.97 |
| August 24, 2026 | 3.87 |
| August 21, 2026 | 3.85 |
| August 20, 2026 | 3.90 |
| August 19, 2026 | 3.96 |
| August 18, 2026 | 3.98 |
| August 17, 2026 | 3.98 |
| August 14, 2026 | 3.97 |
| August 13, 2026 | 3.94 |
| August 12, 2026 | 3.89 |
| August 11, 2026 | 3.91 |
| August 10, 2026 | 4.11 |
| August 07, 2026 | 4.12 |
| August 06, 2026 | 4.10 |
| August 05, 2026 | 4.00 |
| August 04, 2026 | 4.01 |
| August 03, 2026 | 3.97 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| NovelStem International Corp. | 0.0095 |
| Brainstorm Cell Therapeutics, Inc. | 0.8516 |
| Summit Therapeutics, Inc. | 17.13 |
| Kezar Life Sciences, Inc. | 7.29 |
| Clene, Inc. | 3.68 |